Novo, valued at $650 billion in June last year, has shed over two-thirds of its value since. Its latest market cap is around ...

Eli Lilly and Company is gearing up for its second quarter earnings report this Thursday, before the market opens. The pharmaceutical giant has witnessed significant revenue boosts from its ...

While a substantial portion of pipeline assets are externally sourced, many Big Pharmas are tapping into incubators and ...